For CFOs & Finance Directors

You already have more discretion than you exercise.

Volatility isn't going back to episodic. Your facilities and SCF programmes work, but they're slow to flex. Term extensions preserve cash but cost you supplier goodwill. Most CFOs we talk to didn't realise how much usable discretion sits inside the gap between approval and payment. Until they tested it on their own numbers.

GlobalFinex B2B gives finance two governed levers, method and timing, applied selectively and reversibly on approved invoices. If this is your first read, the four-minute version lives on How it Works. The rest of this page is the CFO lens.

If you only read one section here, read the five things CFOs raise on first call.

The portfolio shift

From single tool to portfolio mindset.

You already use multiple working-capital levers. Facilities. Term extension. SCF. Virtual cards. None are wrong. The limitation is that each works best in a specific context, and rigidity emerges when applied universally. The opportunity isn't to replace them. It's to add a deliberate post-approval layer that flexes when they don't.

Optionality preserved as conditions change

Strategy can shift between cash preservation, return generation and supplier support without unwinding programmes or restructuring facilities. Levers are decoupled. Timing changes without changing method.

Liquidity influenced without lending

No balance-sheet impact. No supplier credit underwriting. No external facility. Liquidity timing and method become finance-led decisions on confirmed liabilities, not structural bets.

Selective return on existing supplier spend

Voluntary early settlement at agreed discount captures measurable margin from approved spend. Without forcing suppliers into a programme. Deploy cash where commercial sense exists; leave it where it doesn't.

Supplier relationships protected

Suppliers participate voluntarily, segmentally, on their own terms. Discretion is exercised inside your governance boundary, not forced down the supply chain.

Concerns we hear, addressed

Five things CFOs raise on first call

CFO asset

2026 White Paper. Capital Control Through Supplier Invoice Payments

The 2026 paper does not assume anything is broken. It explores an opportunity that sits quietly inside a reality most finance leaders already recognise. And asks one question:

Do we have sufficient control and optionality over how and when approved liabilities are settled as conditions change?

No form. No gate.

The two CFO outcomes

A CFO using GlobalFinex B2B is usually optimising one of two finance objectives at any given time. Both run through the same post-approval moment, the gap between approval and payment.

  • Working Capital & cashflow. DPO movement, liquidity timing, balance-sheet effect. Working capital view →
  • EBITDA & settlement return. Measurable P&L impact from selective discount capture. EBITDA view →

Curious what this is worth on your spend? Let's model it.

Put your own approved spend and cost of funds into the lever calculator, or take a 30-minute working session with someone who has done this before.

Forward to a colleague?

Same control point, different reader.